Neuroendocrine tumors (NETs) are neoplasms that originate from neuroendocrine cells. They can develop in different organs, including the lungs, pancreas, and gastrointestinal tract. Factors influencing neuroendocrine tumor treatment choice include the tumor’s location, stage, size, and extent of spread.
Primary NET treatment options include surgery, radiation, and drug therapies. Growing incidence of neuroendocrine tumors and rising adoption of different treatments are expected to boost the global NET treatment industry.
What is the demand outlook for neuroendocrine tumor treatments? According to Coherent Market Insights (CMI), global neuroendocrine tumor treatment demand is set to increase at 6.2% CAGR during the forecast period. The total neuroendocrine tumor treatment industry size will likely reach US$ 4.94 billion by 2030.
Comparing Neuroendocrine Tumor Treatments
- Surgery for Neuroendocrine Tumors
Surgery is the gold standard for localized NETs that have not spread. Doctors surgically remove the tumor and any affected lymph nodes nearby.
Benefits
- Completely removes localized tumors
- Reduces symptoms caused by hormone-producing tumors
Disadvantages
- Ineffective against metastatic NETs
- Surgical risks like bleeding and infection
Despite these drawbacks, surgery continues to remain preferred treatment choice for NETs. Robotic-assisted surgery is also gaining traction in NET cure as it significantly improves precision and reduces recovery time.
- Radiation Therapy for Neuroendocrine Cancer
Radiation therapy uses energy waves like X-rays to destroy cancer cells. It is mostly suitable for inoperable NETs. Different types of radiation therapies are used for treating NETs. These include external beam radiation therapy (EBRT) and peptide receptor radionuclide therapy (PRRT).
EBRT targets tumors from outside the body. It is used for inoperable and bone metastases NETs. PRRT is a form of internal radiation that uses radioactive drugs to target specific receptors of NET cells.
Benefits
- Best for advanced NETs
- Non-invasive nature
- Precise targeting
- Symptom reduction
Disadvantages
- May not be curative for all NETs
- Causes side effects
- Drug Therapy for Neuroendocrine Tumors
Drug therapies use different medications to target NET cells and alleviate symptoms. These include
- Somatostatin Analogs: These medications alleviate symptoms by slowing tumor growth and reducing hormone production. Examples include Octreotide and Lanreotide.
- Targeted Therapies: These drugs target specific molecular pathways involved in tumor growth. Everolimus and Sunitinib are prime examples.
- Chemotherapy: It is mostly used for aggressive or metastatic NETs to kill cancer cells. Example drugs include Temozolomide and Streptozocin.
Benefits
- Ideal for advanced NETs
- Slow down tumor progression
- Reduces hormone-related symptoms
Disadvantages
- Cause various side effects
- May not always be effective
Chemotherapy vs. Targeted Therapy in Neuroendocrine Tumors
|
Characteristics |
Targeted Therapy |
Chemotherapy |
|
Target |
Specific Cancer Growth Pathways |
All Rapidly Diving Cells |
|
Suitable For |
Low and Intermediate-grade NETs |
Aggressive NETs |
|
Response |
Slows Tumor Progression |
Shrinks Tumors Quickly |
|
Side Effects |
Mild Side Effects |
More Severe Side Effects |
Multimodal Treatment Approach in Neuroendocrine Tumor Care
Combining surgery, drug therapies, and radiation can be effective in NETs where a single treatment is not sufficient. Doctors use different combinations to treat advanced NETs.
Surgery + Radiation: This combination is used when tumors are localized but have a high risk of recurrence.
Radiation + Drug Therapy: This combination is effective for inoperable or metastatic NETs.
Surgery + Drug Therapy: This combination is employed when surgery removes the tumor, but drug therapy is needed to manage residual disease.
Triple Combination: In advanced or aggressive NETs, all three treatments may be essential for better results.
Choosing best treatment for neuroendocrine tumors depends on tumor location, size, grade, and extent of spread. Surgery will be suitable for combating localized NETs. On the other hand, radiation therapy and drug therapies can be effective for advanced NETs. Many doctors prefer a multimodal approach in neuroendocrine tumor care.
